Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Neoplasia (New York, N.Y.)|June 3, 2008
Cyclic pifithrin-alpha sensitizes wild type p53 tumor cells to antimicrotubule agent-induced apoptosisValentina Zuco, Franco Zunino
Cancer Letters|January 1, 2010
ATM- and ATR-mediated response to DNA damage induced by a novel camptothecin, ST1968Valentina Zuco, Valentina Benedetti, Franco Zunino
Current Pharmaceutical Design|November 28, 2012
Drug combinations with proteasome inhibitors in antitumor therapyLaura Gatti, Valentina Zuco, Nadia Zaffaroni, et al.
Biochemical Pharmacology|August 7, 2010
Modulation of cell sensitivity to antitumor agents by targeting survival pathwaysPaola Perego, Giacomo Cossa, Valentina Zuco, et al.
Biochemical Pharmacology|November 29, 2011
Sensitization of tumor cells by targeting histone deacetylasesPaola Perego, Valentina Zuco, Laura Gatti, et al.
International Journal of Cancer|August 14, 2009
Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: enhanced DNA damage responseValentina Zuco, Valentina Benedetti, Michelandrea De Cesare, et al.
Cancer Research|March 23, 2005
Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839Chiara Zanchi, Valentina Zuco, Cinzia Lanzi, et al.
Oncotarget|April 1, 2015
PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecinsValentina Zuco, Michelandrea De Cesare, Nadia Zaffaroni, et al.
European Journal of Medicinal Chemistry|August 31, 2017
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agentsGiovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
Cell Proliferation|September 14, 2021
δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosisFabrizio Fontana, Monica Marzagalli, Michela Raimondi, et al.
Pageof 7